Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American States Water Company (AWR) vs 10X Genomics Inc (TXG) Price & Performance

American States Water CompanyTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

American States Water Company vs 10X Genomics Inc — how do they compare? American States Water Company trades at $87.28 (market cap $3.47B), while 10X Genomics Inc trades at $57.03 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 2.2× American States Water Company's market cap, and American States Water Company pays a 2.49% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

AWRTXG
Market Cap
$3.47B$7.61B
Sector
UtilitiesHealth
52-Week High
$89.28$58.57
52-Week Low
$70.10$11.34
Enterprise Value
$4.37B$7.14B
Dividend Yield
2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American States Water Company

American States Water (AWR) trades at $87.45, up 1.02% with a bullish technical outlook. The company reported strong Q2 2026 earnings of $1.09 per share, beating estimates, driven by water rate increases and revenue growth of 11.2%. Profitability remains robust with a 20.52% net income margin and ROE of 13.62%. Recent news highlights AWR's 71-year dividend growth streak and inclusion in TIME's America's Best Companies 2026 list.

AWR offers stable income with consistent dividend growth but faces valuation concerns at 23.92 P/E. Analyst consensus is cautious with 50% hold ratings. Key risks include regulatory dependence and competitive pressures. The stock presents a defensive play with reliable dividends but limited near-term upside given current multiples.

10X Genomics Inc

TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.

Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American States Water Company

American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.

Read more on AWR

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG